Position in ATHE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$332,940
+$221,580 QoQ
Shares Held
62,000
+93.8% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 22 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATHE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREENLEAF TRUST holds $5,442,452 across 8 Biotechnology names. ATHE ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,995 | $2,481,165 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,353 | $843,649 | |
| 3 | ARGX |
Argenx SE
|
620 | $575,217 | |
| 4 | INCY |
Incyte Corp
|
3,358 | $380,662 | |
| 5 | MRNA |
Moderna, Inc.
|
4,964 | $347,628 | |
| 6 | ATHE |
Alterity Therapeutics Ltd
This page
|
62,000 | $332,940 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,560 | $248,109 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,157 | $233,082 |
All Filings in ATHE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,940 | 62,000 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $111,360 | 32,000 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $98,560 | 32,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $120,320 | 32,000 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $69,530 | 17,000 | Shares | Sole | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||